Investigating the effect of probiotics in the treatment of Helicobacter pylori infectio

Phase 3

• Conditions: Patients with Helicobacter pylori infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20240222061080N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with Helicobacter pylori infection
Age 18 to 75 years

Exclusion Criteria

Gastric cancer
Kidney and liver failure
History of gastric surgery
Pregnancy and breastfeeding
Unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The recurrence rate of Helicobacter pylori in patients. Timepoint: 4 weeks after treatment. Method of measurement: Fecal antigen test.

Secondary Outcome Measures

Name	Time	Method
The incidence of complications and improvement of clinical symptoms in patients. Timepoint: 4 weeks after the end of the intervention. Method of measurement: Clinical examination in terms of pain or burning in the abdomen and the affected area below the ribs and above the navel.